386 related articles for article (PubMed ID: 19367480)
1. Tacalcitol ointment for the treatment of nail psoriasis.
Márquez Balbás G; Sánchez Regaña M; Umbert Millet P
J Dermatolog Treat; 2009; 20(5):308-10. PubMed ID: 19367480
[TBL] [Abstract][Full Text] [Related]
2. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
Lecha M; Mirada A; López S; Artés M;
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
[TBL] [Abstract][Full Text] [Related]
3. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment.
Sánchez Regaña M; Márquez Balbás G; Umbert Millet P
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):963-9. PubMed ID: 18410337
[TBL] [Abstract][Full Text] [Related]
4. Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris.
Miyachi Y; Ohkawara A; Ohkido M; Harada S; Tamaki K; Nakagawa H; Hori Y; Nishiyama S
Eur J Dermatol; 2002; 12(5):463-8. PubMed ID: 12370136
[TBL] [Abstract][Full Text] [Related]
5. Topical calcipotriol therapy in nail psoriasis: a study of 24 cases.
Zakeri M; Valikhani M; Mortazavi H; Barzegari M
Dermatol Online J; 2005 Dec; 11(3):5. PubMed ID: 16409901
[TBL] [Abstract][Full Text] [Related]
6. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
Zhu X; Wang B; Zhao G; Gu J; Chen Z; Briantais P; Andres P
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
[TBL] [Abstract][Full Text] [Related]
7. Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment.
Rigopoulos D; Gregoriou S; Daniel Iii CR; Belyayeva H; Larios G; Verra P; Stamou C; Kontochristopoulos G; Avgerinou G; Katsambas A
Dermatology; 2009; 218(4):338-41. PubMed ID: 19212110
[TBL] [Abstract][Full Text] [Related]
8. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety.
Van de Kerkhof PC; Werfel T; Haustein UF; Luger T; Czarnetzki BM; Niemann R; Plänitz-Stenzel V
Br J Dermatol; 1996 Nov; 135(5):758-65. PubMed ID: 8977677
[TBL] [Abstract][Full Text] [Related]
9. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
Lahfa M; Mrowietz U; Koenig M; Simon JC
Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
[TBL] [Abstract][Full Text] [Related]
10. Nail psoriasis improvement in a patient treated with fumaric acid esters.
Vlachou C; Berth-Jones J
J Dermatolog Treat; 2007; 18(3):175-7. PubMed ID: 17538807
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of topical tacalcitol efficacy in extending the remission period between nb-UVB phototherapy cycles in psoriatic patients.
Prignano F; Buggiani G; Lotti T
Acta Biomed; 2009 Apr; 80(1):51-6. PubMed ID: 19705621
[TBL] [Abstract][Full Text] [Related]
12. Daily versus intermittent application of high-concentration tacalcitol ointment in combination with low-dose cyclosporin for psoriasis vulgaris.
Abe M; Syuto T; Hasegawa M; Sogabe Y; Yokoyama Y; Ishikawa O
J Dermatol; 2006 Feb; 33(2):108-11. PubMed ID: 16556277
[TBL] [Abstract][Full Text] [Related]
13. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
14. Calcipotriol plus betamethasone dipropionate gel compared with tacalcitol ointment and the gel vehicle alone in patients with psoriasis vulgaris: a randomized, controlled clinical trial.
Langley RG; Gupta A; Papp K; Wexler D; Østerdal ML; Curčić D
Dermatology; 2011; 222(2):148-56. PubMed ID: 21293107
[TBL] [Abstract][Full Text] [Related]
15. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial.
Veien NK; Bjerke JR; Rossmann-Ringdahl I; Jakobsen HB
Br J Dermatol; 1997 Oct; 137(4):581-6. PubMed ID: 9390335
[TBL] [Abstract][Full Text] [Related]
16. Rheological properties of three different vitamin D ointments and their clinical perception by patients with mild to moderate psoriasis.
Marty JP; Lafforgue C; Grossiord JL; Soto P
J Eur Acad Dermatol Venereol; 2005 Nov; 19 Suppl 3():7-10. PubMed ID: 16274405
[TBL] [Abstract][Full Text] [Related]
17. Management of psoriasis with calcipotriol used as monotherapy.
Ramsay CA
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S53-4. PubMed ID: 9344185
[TBL] [Abstract][Full Text] [Related]
18. Calcipotriol ointment versus cream in psoriasis vulgaris.
Duweb G; Aldebani S; Elzorghany A; Benghazil M; Alhaddar J
Int J Clin Pharmacol Res; 2003; 23(2-3):47-51. PubMed ID: 15018018
[TBL] [Abstract][Full Text] [Related]
19. Tacalcitol: A useful adjunct to narrow band ultraviolet B phototherapy in psoriasis.
Aggarwal P; Aggarwal K; Jain VK
J Dermatolog Treat; 2016 Nov; 27(6):546-551. PubMed ID: 27052200
[TBL] [Abstract][Full Text] [Related]
20. The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity.
Queille-Roussel C; Duteil L; Parneix-Spake A; Arsonnaud S; Rizova E
Eur J Dermatol; 2001; 11(3):219-24. PubMed ID: 11358728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]